Karriereverlauf von Georges Rawadi
Ehemalige bekannte Positionen von Georges Rawadi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Direktor/Vorstandsmitglied | 27.04.2023 | 01.12.2023 |
| Vorstandsvorsitzender | 27.04.2023 | 01.12.2023 | |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Direktor/Vorstandsmitglied | 01.03.2018 | 01.09.2021 |
| Vorstandsvorsitzender | 01.03.2018 | 01.09.2021 | |
| CELYAD ONCOLOGY SA | Corporate Officer/Principal | 01.06.2014 | 23.03.2018 |
| CELLECTIS S.A. | Corporate Officer/Principal | - | - |
Ausbildung von Georges Rawadi
| ESSEC Business School | Graduate Degree |
Statistik
International
| Frankreich | 5 |
| Belgien | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| CELLECTIS S.A. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
- Börse
- Insiders
- Georges Rawadi
- Erfahrung
